Leveraged & Inverse ChannelPILL Hasn’t Been a Bitter ETF to Swallow The Past MonthBy Ben HernandezDecember 23, 2020
Leveraged & Inverse ChannelDirexion to Change Indexes For Leveraged Pharma, Real Estate ETFsBy Todd ShriberJune 4, 2019
Beyond Basic Beta Channel4 ETFs to Consider with Big Pharma on the Senate’s Hot SeatBy Ben HernandezApril 9, 2019
Leveraged & Inverse ChannelBig Biopharma Mergers Could Fuel These ETFs in 2019By Ben HernandezJanuary 10, 2019
Leveraged & Inverse ChannelPharma Earnings: The PILL to CURE Market Troubles?By DirexionNovember 1, 2018
FeaturedDirexion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFsBy Tom LydonSeptember 16, 2015
